Overview

• MP’s Special Investigation Team says Sresan Pharma procured industrial‑grade diethylene glycol for Coldrif and is mapping suppliers, quality control staff and distributors, with the owner in 10 days’ police custody.
• Fresh samples from the same May 2025 batch failed testing, with government labs reporting roughly 46–48.6% diethylene glycol against a 0.1% limit, and Tamil Nadu has sealed the manufacturing unit.
• Delhi and West Bengal joined Madhya Pradesh, Tamil Nadu, Punjab and Maharashtra in prohibiting the syrup, while Delhi officials said no consignment entered the capital and began wider market sampling.
• The Drugs Controller General of India ordered DEG/EG testing for both raw materials and finished formulations and held a review with states to tighten enforcement and guide safer pediatric cough‑syrup use.
• At least 22 children have died, several remain critically ill in Nagpur hospitals, and doctors’ bodies are protesting the arrest of a Chhindwara pediatrician as political calls grow for resignations and a CBI inquiry.